1021 Talbotton Road
Columbus, GA 31904 |
|
|
|
PERSONAL |
|
|
Name
William Madison Harper IV, M.D.
Born
March 26, 1953
Marital Status
Married: Elinor Harper
Four Children: Madison, Marc, Carson and Martin |
EDUCATION
|
Undergraduate Information |
|
|
High School |
Plains High School, Plains, GA 1970 |
|
College and Degree: |
Georgia Southwestern, Americus, GA
B.S. in Biology & Chemistry 1974
|
|
|
|
|
Graduate Education |
|
|
College and Degree: |
Medical College of Georgia Augusta, GA M.D. 1978
|
Honors
Member:
Beta Club National Honor Society, Plains High School
Phi Kappa National Honor Society, GA. Southwestern University
Alpha Omega Alpha National Academic Medical Honor Society, Medical College of GA. |
|
|
|
|
Post Graduate Education |
|
|
Internship in Surgery: |
Medical College of Georgia, Augusta, GA 1978-1979
|
|
Resident in Surgery: |
Medical College of Georgia, Augusta, GA 1979-1980 |
|
Resident in Urology : |
Medical College of Georgia, Augusta, GA 1980-1982
|
|
Chief Resident of Urology: |
Medical College of Georgia, Augusta, GA 1982-1983
|
|
Professional Education |
|
|
|
American Board of Urology, Board Certified 1985, Recertified 1994
Certified Clinical Trial Investigator 2005, by Association of Clinical Research
Professionals
Certified Clinical Densitometrist (CCD) 9/22/2005, by The International Society
for Clinical Densitometry |
|
|
|
|
Licensure |
|
|
Georgia Licens # 020726 |
|
|
Alabama License# 00010803 |
|
|
|
|
|
PRIVATE PRACTICE
|
PROFESSIONAL & OTHER AFFILIATIONS |
Urology Center of Columbus, LLC
1021 Talbotton Road
Columbus, GA 31904
(706) 324-7700
(706) 324-7080 fax |
Southeastern Medical Research Institute
CEO and Medical Director
2100 North Avenue
Columbus, GA 31904
(706) 653-9637 (706) 324-7080 Fax |
|
|
|
Hospital Affiliations |
Doctor’s Hospital:
Medical Center Hospital:
St. Francis Hospital:
Phenix Regional Hospital:
Hughston Sports Medicine Hospital:
Ambulatory Surgery Center |
Columbus, GA.
Columbus, GA
Columbus, GA
Phenix City, AL
Columbus, GA
Columbus, GA |
Active
Active
Active
Courtesy
Courtesy
Active |
1983-present
1983-present
1983-present
1983-2001 (Hospital closed)
1983-present
2000-present |
|
|
|
Clinical Faculty |
|
Medical Center 1983 |
|
|
|
Member |
Muscogee County Medical Society
Muscogee County Physicians Foundation
Medical Association of Georgia
Chattahoochee Valley Urological Society
Southeastern American Urological Association
American Medical Association
American Urological Association
Impotence Institute of America
American Fertility Society
Society for the Study of Impotence
International Society for the Study of Impotence
International Society for Impotence Research
American Academy of Male Sexual Health
Rotary Club
Big Eddy Club
Association of Clinical Research Professionals ID#158629
American College of Surgeons ID#03087559 |
|
|
|
PROFESSIONAL & OTHER AFFILIATIONS (cont’d) |
|
Positions |
|
|
Medical Executive Committee
Chief of Staff
Chief of Surgery
Board of Trustees
Chief of Urology
Medical Executive Committee
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Chairman
Chairman
Board of Directors |
Doctor’s Hospital
Doctor’s Hospital
Doctor’s Hospital
Doctor’s Hospital
St. Francis Hospital
St. Francis Hospital
U.S. Diagnostic Labs, Inc.
South GA. Lithotripsy Associates
Quality Healthcare Partnership
American Cancer Society
Columbus Physicians Association
Physician’s Group Inc.
Columbus Health Education& Research Foundation |
1990-1996
1992-1994
1992-1994
1993-Present
1991-1993
1991-1993
1994-1996
1992-1999
1999-2001
Present
1998- 2000
1996- 1998
1999- 2000 |
|
|
|
|
|
Member |
Association of Clinical Research Professionals |
Present |
|
|
|
|
Board of Directors
Chairman |
Institute for Healthcare Leadership 1st Annual Men’s Health & Fitness
Conference & Expo |
2001- 2002
2000 |
Past President
Past President
Past President
First Chairman
Executive Committee Member
Board of Directors
Advisory Board Member |
Chattahoochee Valley Urological Society
Muscogee Co. Medical Society
Muscogee Co. Physicians Foundation
GA Commission on Men’s Health
Muscogee Co. Physicians Foundation
Columbus Research Foundation, Inc.
Men’s Health Network |
2000-2001
2002
2001
2001- Present
2002
2002-Present
2004-Present |
|
|
|
|
|
AWARDS |
|
|
|
Physician Of the Year |
Muscogee County Medical Society |
2000 |
FUNDED RESEARCH
Overactive Bladder/Stress Urinary Incontinence
Protocol 583E-URO-0084-023 – Principle Investigator
A Patient Acceptability Study of a Once-Daily Formulation of ******. A Phase IIIB,
Open-Label, Single-Arm Trial in Adult Patients with overactive Bladder and symptoms
of Urinary frequency, Urgency, and/or Urge Incontinence.
Protocol: F1J-US-SBCD Principle Investigator
Study of ************ in Women of Different Demographic Characteristics and Co-morbidities
with Stress Urinary Incontinence: Evaluation of Efficacy and Safety.
Protocol: A6121120 Pfizer Pharmaceuticals 2005
A randomized, double-blind, placebo controlled, four arm (*****, *****, *****, and
***** plus *****) study to evaluate the clinical efficacy and safety of ***** in
men who have frequency and urgency, with or without urinary urge incontinence, with
or without bladder outlet obstruction.
Interstitial Cystitis
Protocol MN-001-CL-002 Principle Investigator
A Phase II Randomized, Double-Blind, Placebo-Controlled, Multicenter study to Evaluate
the Efficacy and Safety of Two Dosing Regimens of ***** in Patients with Interstitial
Cystitis.
Vulvar and Vaginal Atrophy
Protocol: 15-50310 Principle Investigator
Efficacy and Safety of ****** in the Treatment of Vulvar and Vaginal Atrophy (VVA)
in Post Menopausal Women: A 12 Week Randomized, Double-Blind, Placebo-Controlled,
Parallel-Group Study Comparing ****** and ******* Daily Doses with Placebo.
Protocol: 15-50310x Principle Investigator
Long-Term Safety of ******* and ****** Oral Daily Doses of ****** in the Treatment
of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women with an Intact Uterus:
A 40-Week Randomized, Double-Blind, Placebo-Controlled, Follow-Up to Protocol 15-15310.
Protocol: 15-50312 Principle Investigator
Long-Term Safety of ******* Oral Daily for the Treatment of Vulvar and Vaginal Atrophy
(VVA) in Postmenopausal Women without an Uterus: A 52-Week Open-Label Follow-Up
to Protocol 15-15310.
Prostate Cancer
Protocol M97-786 – Principle Investigator
Randomized Prospective Study of Adjuvant Androgen Ablation in Radical Prostatectomy
Patients at High-Risk for Disease Reoccurrence.
Protocol 7054US/0007– Principle Investigator
Randomized Double- Blind Comparative Trial of *********** (*******) 150mg vs Placebo
Each in Combination With Castration as Second-Line Therapy for Patients With Asymptomatic
Metastatic Prostate Cancer.
Principle Investigator
Investigation to Determine the Efficacy of Circulating Total Prostate Specific Antigen
(PSA) as an Aid in the Early Detection of Prostate Cancer. Diagnostic Oncology CRO
Inc., 1999
Principle Investigator
Investigation to Determine the Efficacy of Circulating Free Prostate Specific Antigen
(F-PSA) and the Ration of Concentrations of Circulating F-PSA to PSA as an Aid in
the Early Detection of Prostate Cancer. Diagnostic oncology CRO, Inc. 1999
Protocol: MPR-7869-001 Principle Investigator
Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess
the Safety and Efficacy of ***** in Delaying the Systemic Progression of Prostate
Cancer in Patients with Intermediate to High Risk of Recurrence with Rising PSA
Levels After Prostatectomy and Radiotherapy or Radiotherapy Alone for Localized
Disease.
Myriad Pharmaceuticals 2002.
Protocol: TBC-PRO-002 Principle Investigator
A Phase II Randomized, Double Blind, Controlled Study to Evaluate the Safety and
Efficacy of ******/******* in Combination with GM-CSF in Patients with Androgen-Independent
Adenocarcinoma of the Prostate.
Protocol: L8891 Principle Investigator
Prospective, Observational Registry of the Management of Men with Prostate Cancer
and a Rising PSA Following Definitive Surgical or Radiological Treatment of the
Primary Tumor: PCA Registry COMPARE
Protocol: G300203 GTX Inc. 2005
A randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety
of ***** ** for the Prevention of Bone Fractures in Men with Prostate Cancer on
Androgen Deprivation Therapy.
Protocol: 20050103 Principle Investigator
A Randomized, Double-Blind, Multicenter study of ******** Compared with Zoledronic
Acid (Zometa) in the Treatment of Bone Metastases in Men with Hormone-Refractory
Prostate Cancer.
Protocol: 20050147
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase III Study of
******* on Prolonging Bone Metastasis-Free Survival in Men with Hormone-Refractory
Prostate Cancer.
Bladder Cancer
Protocol CO 98803/DFMO-341– Principle Investigator
Phase III Randomized, Double-Blind Study of ***** vs Placebo in Low Grade Superficial
Bladder Cancer.
Erectile Dysfunction
Protocol M01-293– Principle Investigator
A Phase III, Double-Blind, Randomized, Parallel Study Evaluating the Efficacy and
safety of ******* (********* tablets) Sublingual (2 and 3mg) in the Treatment of
Male Erectile Dysfunction.
Protocol M99-031– Principle Investigator
Phase III at Home Use Study Evaluating Efficacy and safety of Escalating Doses of
******* 2,3 and 4mg in the Treatment of Patients With Erectile Dysfunction.
Protocol M99-038– Principle Investigator
Phase III, 6 Month, Long-Term, Open Label Flexible Dose, Safety Extension Study
of ****** Tablets (2,3 and 4mg) in the Treatment of Male Erectile Dysfunction.
Protocol: H6D-MC-LVFN(b) Principle Investigator
An Open-Label Study to Evaluate the Efficacy and Safety of Tadalafil Administered
'On Demand" to Men of Various Populations with Erectile Dysfunction.
Protocol: M01-296. TAP Pharmaceuticals. 2002
A Phase III, 12-month, open-label, felixble dose, safety extension study of ********
tablets (2 and 3mg) in the treatment of male erectile dysfunction.
Benign Prostatic Hyperplasia (BPH)/Prostatitis
Protocol EFC-4428– Principle Investigator
A Double-Blind Randomized Parallel Group Study of ********** 10mg OD Versus Placebo
in the Management of Acute Urinary Retention in Patients With a First Episode Due
to BPH.
Protocol CAPSS-101– Principle Investigator
A Multi-Center, Double-Blind Study to Compare the Safety and Efficacy of ***********
to that of *********** in the Treatment of Chronic Prostatitis.
Principle Investigator
Evaluation of Biomarkers for the Diagnosis and Management of Prostatic Diseases.
BioClinical Partners, Inc., Franklin, MA 1999
Principle Investigator
Multicenter, Double-Blind Study to Compare the Safety and Efficacy of ************
to that of ********** in the Treatment of Chronic and recurrent Prostatitis. Ortho-McNeil
Pharmaceuticals 1999
Protocol: L8890 Principle Investigator
'Prospective Observational Registry and Patient Survey of the Management of Men
with Symptomatic Benign Prostatic Hyperplasia (BPH): BPH Registry and Patient Survey"
Adult Growth Hormone DeficiencyProtocol CAW G/G 1991–
Principle Investigator
Effects of Growth hormone (GH) or Growth Hormone Releasing Hormone (GRF) on Age-Related
Insulin resistance, pulmonary Function and Quality of Life.
Protocol: 85-036EXT. Genetech Pharmaceuticals.
National Cooperative Somatropin Surveillance (NCSS) of Nutropin AQ and Nutropin
Replacement Therapy in adults with Growth Hormone Deficiency.
Protocol: L3339n Principle Investigator
Genentech National Cooperative Metabolic Study (NCMS) of Nutropin AQ [somatropin
(rDNA origin) injection] and Nutropin [somatropin (rDNA origin) for injection] Replacement
Therapy in Adults with Growth Hormone Deficiency.
Urinary Tract Infections
Protocol (100286) Bay 56-5864– Principle Investigator
Prospective Randomized, Double-Blind Study Comparing ************ 300mg PO BID for
Five Days With ********/*********** 160/800mg PO BID for Five Days in the Treatment
of Patients With Acute, Uncomplicated Lower Urinary Tract Infections.
Protocol: CAPSS-292 Principle Investigator
A Double-Blind, Randomized, Parallel Group Trial of Ditropan XL (oxybutynin chloride)
Extended Release Tablets or Placebo in Combination with FLOMAX (tamsulosin hydrochloride)
For The Treatment of Lower Urinary Tract Symptoms.
Protocol: CAPSS-349 Ortho-McNeil Pharmaceuticals 2005
A Study to Compare the Safety and Efficacy of Once Daily ****** versus Twice Daily
***** in the Treatment of Complicated Urinary Tract Infection and Acute Uncomplicated
Pyelonephritis.
Investigator Initiated TrialsProtocol MF SHIMMED–
Principle Investigator
Sponsor: William M. Harper IV, MD
Minority Focused Sexual Health Inventory for Men as Model for evaluation and Detection
of Men’s Health Issues.
Protocol: X3397n
The Incidence of Adult Growth Hormone Deficiency Secondary to Pituitary Adenomas
and Head trauma in Hypogonadal Males Presenting in the Urological Practice.
Lectureships
|
May 10, 2000 |
Sunshine Biscuits. Columbus, Georgia 'Men’s Health" |
|
|
|
|
May 23, 2000 |
Kiwanis Club of Columbus. Columbus, Georgia 'Men’s Health" |
|
|
|
|
June 16, 2000 |
First Annual Men’s Health and Fitness Conference and Expo. Columbus, Georgia'Male
exuality" |
|
|
|
|
January 20, 2001 |
Diabetes University. Columbus Trade Center American Diabetes Association. Columbus,
Georgia. 'Erectile Dysfunction and Diabetes" |
|
|
|
|
March 8, 2001 |
Alza Pharmaceuticals. Columbus, Georgia 'Urinary Incontinence" |
|
|
|
|
April 3, 2001 |
OPALS Health Seminar. Columbus, Georgia 'A Nation’s Healthcare Crisis and
Georgia’s Solution HB 1235" |
|
|
|
|
April 24, 2001 |
Grand Rounds. The Medical Center. Columbus, Georgia 'A Nation’s Healthcare
Crisis and Georgia’s Solution HB 1235" |
|
|
|
|
August 6, 2001 |
PHRMa Task Force. Atlanta, Georgia 'A Nation’s Healthcare Crisis and Georgia’s
Solution HB 1235" |
|
|
|
|
August 7, 2001 |
Tri County Medical Society. Warm Springs, Georgia 'A Nation’s Healthcare Crisis
and Georgia’s Solution HB 1235" |
|
|
|
|
September 25, 2001 |
Grand Rounds. The Medical Center. Columbus, Georgia 'One to One" Erectile Dysfunction. |
|
|
|
|
September 25, 2001 |
Health Matters. St. Francis Hospital Columbus, Georgia. 'Prostate Diseases" |
|
|
|
|
October 25, 2001 |
Physicians Leadership Forum. Columbus, Georgia 'A Nation’s Healthcare Crisis
and Georgia’s Solution HB 1235" |
|
|
|
|
October 27, 2001 |
Health in Action. Buick Challenge at Calloway Gardens. 'A Nation’s Healthcare
Crisis and Georgia’s Solution HB 1235" |
|
|
|
|
January 12, 2002 |
Diabetes University. Columbus Trade Center American Diabetes Association. Columbus,
Georgia. 'Erectile Dysfunction and Diabetes" |
|
|
|
|
January 24, 2002 |
Fort Benning Medical Society. Columbus, GA 'One to One" |
|
|
|
|
January 28, 2002 |
Pfizer Pharmaceuticals. Little Rock, AR 'One to One" |
|
|
|
|
January 29, 2002 |
Pfizer Pharmaceuticals. Little Rock, AR 'One to One" |
|
|
|
|
January 29, 2002 |
Pfizer Pharmaceuticals. Memphis, TN 'One to One" |
|
|
|
|
February 5, 2002 |
Grand Rounds. The Medical Center. Columbus, Georgia 'One to One" |
|
|
|
|
February 7, 2002 |
Ortho McNeil Pharmaceuticals. Columbus, Georgia 'Stress Urinary Incontinence" |
|
|
|
|
February 28, 2002 |
Diabetes Support Group. The Medical Center. Columbus, GA. 'Erectile Dysfunction
and Diabetes" |
|
|
|
|
March 5-6, 2002 |
ED Expert Advisory Panel. Pfizer Pharmaceuticals. Atlanta, Georgia. 'One to One" |
|
|
|
|
March 7, 2002 |
Pfizer Pharmaceuticals. Springer Opera House. Columbus, Georgia. 'One to One" |
|
|
|
|
March 13, 2002 |
Grand Rounds. Valley, Alabama 'One to One" |
|
|
|
|
April 16, 2002 |
Georgia Association of Physicians Assistants. Columbus, Georgia. 'One to One" |
|
|
|
|
April 19, 2002 |
Health Matters. St. Francis Hospital. 'Stress Urinary Incontinence" |
|
|
|
|
April 29-30, 2002 |
Pfizer Pharmaceuticals. Birmingham, Alabama 'One to One" |
|
|
|
|
May 1, 2002 |
Rotary of Columbus. Columbus, Georgia 'One to One" |
|
|
|
|
July 18, 2002 |
Pfizer Pharmaceuticals. Columbus, Georgia 'One to One" |
|
|
|
|
August 19, 2002 |
Solvay Pharmaceuticals. Columbus, Georgia 'The Clinical Importance of Identifying
and Treating Hypogonadism" |
|
|
|
|
September 28, 2002 |
Nichols Chapel. Phenix City, Alabama ' Prostate Cancer" |
|
|
|
|
October 15, 2002 |
Pfizer Pharmaceuticals. Columbus, Georgia ' One to One" |
|
|
|
|
January 13, 2003 |
Pfizer Pharmaceuticals. Columbus, Georgia Columbus Clinic. 'One to One" |
|
|
|
|
January 15, 2003 |
American Medical Systems. Columbus, Georgia TVT Sling Seminar |
|
|
|
|
January 16, 2003 |
Pfizer Pharmaceuticals. Columbus, Georgia GA Physicians Assistant Organization.
'One to One" |
|
|
|
|
March 12, 2003 |
Pfizer Pharmaceuticals. Columbus, Georgia "PROVEN" |
|
|
|
|
March 21, 2003 |
Pfizer Pharmaceuticals. Columbus, Georgia “ PROVEN” |
|
|
|
|
April 1, 2003 |
Pfizer Pharmaceuticals. Columbus, Georgia “ PROVEN” |
|
|
|
|
April 19, 2003 |
Pfizer Pharmaceuticals. Columbus, Georgia Chattahoochee Valley Urological Society
“Erectile Dysfunction” |
|
|
|
|
April 29, 2003 |
American Medical Systems. Columbus, Georgia “Erectile Dysfunction” |
|
|
|
|
May 13, 2003 |
Pfizer Pharmaceuticals. Columbus, Georgia Grand Rounds at the Medical Center “PROVEN” |
|
|
|
|
June 1, 2003 |
Genentech Pharmaceuticals. San Francisco, CA “Adult Growth Hormone Deficiency” |
|
|
|
|
June 13, 2003 |
Genentech Pharmaceuticals “Adult Growth Hormone Deficiency” |
|
|
|
|
June 17, 2003 |
Pfizer Pharmaceuticals. Columbus, Georgia “PROVEN” Columbus Naval Museum |
|
|
|
|
September 23, 2003 |
Pfizer Pharmaceuticals. Columbus, Georgia “Proven” Green Island Country
Club |
|
|
|
|
October 28, 2003 |
Pfizer Pharmaceuticals. Columbus, GA “Proven” Miriam’s Cafe |
|
|
|
|
November 11, 2003 |
Pfizer Pharmaceuticals. Warm Springs, GA. Steakhouse.“Treatment of Urological
Diseases for Primary Car & ED” |
|
|
|
|
February 3, 2004 |
Pfizer Pharmaceuticals. Columbus, GA. Gre Island Country Club.“Treatment of
Urological Diseases for Primary Car & ED” |
|
|
|
|
March 10, 2004 |
Pfizer Pharmaceuticals. Columbus, GA. Medical C “Treatment of Urological Diseases
for Primary Car & ED” |
|
|
|
|
April 13, 2004 |
Pfizer Pharmaceuticals. Montgomery, AL “Treatment of Urological Diseases for
Primary Car& ED” |
|
|
|
|
April 19, 2004 |
Pfizer Pharmaceuticals. Columbus, GA. Urology C “Overactive Bladder” |
|
|
|
|
June 24, 2004 |
Pfizer Pharmaceuticals. Ft. Benning, Martin Army Hospital “Overactive Bladder” |
|
|
|
|
July 14, 2004 |
Pfizer Pharmaceuticals. Columbus, Beth Martin’s office “Proven” |
|
|
|
|
July 27, 2004 |
Pfizer Pharmaceuticals. Columbus, GA. River Club “Proven” |
|
|
|
|
July 28, 2004 |
Pfizer Pharmaceuticals. Columbus, GA. River Club “Proven” |
|
|
|
|
August 3, 2004 |
Pfizer Pharmaceuticals. Columbus, GA. River Club “Proven” |
|
|
|
|
August 25, 2004 |
Pfizer Pharmaceuticals. Columbus, GA. River Club “Proven” |
|
|
|
|
August 26, 2004 |
Pfizer Pharmaceuticals. Anniston, AL Lunch and dinner round table discussions on
ED. |
|
|
|
|
September 28, 2004 |
Pfizer Pharmaceuticals. Columbus, GA. Buckhead “Powerful Performance, When
You Want It” |
|
|
|
|
October 5, 2004 |
Pfizer Pharmaceuticals, Buena Vista, GA Lunch round table discussion on ED. |
|
|
|
|
October 26, 2004
|
Pfizer Pharmaceuticals. Columbus, GA. The Medical Center Grand Rounds “Overactive
Bladder” |